LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 14.50 | 770.25 | 1132 | 1497 | 0.7561 | 0.4941 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 16.73 | 770.25 | 1485 | 1664 | 0.8922 | 0.8049 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 16.73 | 770.25 | 1189 | 1664 | 0.7143 | 0.4778 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 18.95 | 770.25 | 1532 | 1832 | 0.8360 | 0.7331 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 18.95 | 770.25 | 1189 | 1832 | 0.6488 | 0.4151 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 21.17 | 770.25 | 1495 | 2008 | 0.7444 | 0.6155 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 21.17 | 770.25 | 1276 | 2008 | 0.6353 | 0.4406 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 23.39 | 770.25 | 1605 | 2244 | 0.7151 | 0.6093 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 23.39 | 770.25 | 1298 | 2244 | 0.5783 | 0.4024 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 25.62 | 770.25 | 1615 | 2514 | 0.6422 | 0.5430 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 25.62 | 770.25 | 1343 | 2514 | 0.5340 | 0.3850 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 27.84 | 770.25 | 1674 | 2833 | 0.5907 | 0.5114 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 27.84 | 770.25 | 1427 | 2833 | 0.5036 | 0.3883 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 30.06 | 770.25 | 1729 | 3106 | 0.5566 | 0.4947 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 30.06 | 770.25 | 1535 | 3106 | 0.4942 | 0.4089 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 32.28 | 770.25 | 1859 | 3392 | 0.5479 | 0.5097 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 32.28 | 770.25 | 1684 | 3392 | 0.4963 | 0.4415 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 34.50 | 770.25 | 1985 | 3712 | 0.5348 | 0.5178 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 34.50 | 770.25 | 1859 | 3712 | 0.5008 | 0.4745 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 36.73 | 770.25 | 2112 | 4086 | 0.5169 | 0.5204 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 36.73 | 770.25 | 2011 | 4086 | 0.4922 | 0.4898 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 38.95 | 770.25 | 2325 | 4543 | 0.5117 | 0.5395 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 38.95 | 770.25 | 2173 | 4543 | 0.4782 | 0.4994 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.17 | 770.25 | 2491 | 5010 | 0.4971 | 0.5441 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.17 | 770.25 | 2412 | 5010 | 0.4814 | 0.5258 | MN20160304_L02 | H18 |